- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Gregory L. Fricchione, MD, Discusses Health Reform's Role in Psychiatry and Clinical Medicine
Gregory L. Fricchione, MD, of Harvard Medical School, says that patients suffering from non-communicable disease face a number of challenges.
Gregory L. Fricchione, MD, of Harvard Medical School, says that patients suffering from non-communicable disease face a number of challenges.
“The thought leaders in medicine are realizing that these non-communicable diseases—which include cardiovascular diseases, arthritises, chronic pulmonary diseases, and neuropsychiatric disorders—these non-communicable diseases are really going to be the biggest health challenge in the 21st century,” says Dr Fricchione.
He says other challenges include patients’ suffering from the side effects and stress associated with their illness, along with the costs of managing their care. Psychiatrists and clinical neuroscientists have much to offer primary and specialty healthcare providers because they “have an in-depth understanding of how the mind, brain, and body interact.” Working together, they can reform the care management of patients with non-communicable diseases.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
